Corona, CA (Aug. 2)—
Watson Pharmaceuticals
announced that Allen Chao, Ph.D., 61, its chairman, president and chief executive officer, will retire as president and chief
executive officer, effective September 4, 2007. Chao will be succeeded by Paul M. Bisaro, 46, currently president and chief
operating officer of
Barr Pharmaceuticals
(Woodcliff Lake, NJ), who has been named president and chief executive officer of Watson, effective September 4, 2007. Bruce
L. Downey, Barr's chairman and chief executive officer, will assume these responsibilities on an interim basis.
Abbott Park, IL (Aug. 3)—Richard A. Gonzalez, president and chief operating officer, and a member of
Abbott's
board of directors, plans to retire after a 30-year career with the company. Gonzalez will remain with Abbott until Sept.
30, 2007.
Thousand Oaks, CA (Aug. 2)—
Amgen
announced that Dennis Fenton, executive vice-president of operations, has elected to retire at the end of 2007 after 25 years
with the company.
San Diego, CA (Aug. 2)—
BioDuro, a life-sciences outsourcing company for the pharmaceutical and biotechnology industry with headquarters in San Diego, CA,
and laboratory facilities in Beijing, China, appointed Steven M. Hutchins to the position of vice-president, business development
and collaboration management.
Paris (Aug. 1)—David J. Williams relinquished his titles of president and chief executive officer of
Sanofi Pasteur,
the vaccines division of the
Sanofi-Aventis Group
. He will continue to serve as chairman of the board of Sanofi Pasteur until January 16, 2008, which will also mark his 30th
anniversary with the company. His successor will be Wayne Pisano, formerly senior vice-president, global commercial operations
and corporate strategy.
|
